Vascular endothelial growth factor gene polymorphisms in giant cell arteritis

Luigi Boiardi, Bruno Casali, Davide Nicoli, Enrico Farnetti, Qingquan Chen, Pierluigi Macchioni, Maria Grazia Catanoso, Lia Pulsatelli, Riccardo Meliconi, Carlo Salvarani

Research output: Contribution to journalArticle

62 Citations (Scopus)

Abstract

Objective. To examine potential associations of vascular endothelial growth factor (VEGF) gene polymorphisms with giant cell arteritis (GCA) and disease expression, in particular in patients with and without ischemic complications. Methods. We enrolled 92 consecutive patients with biopsy-proven GCA residing in Reggio Emilia, Italy. Two hundred healthy blood donors from the same geographic area were selected as controls. All the GCA patients and controls were genotyped by polymerase chain reaction and allele-specific oligonucleotide techniques for 936 C/T and 634 C/G mutations and for an 18 bp insertion/deletion (I/D) polymorphism in the VEGF promoter region. In vitro release of VEGF by peripheral blood mononuclear cells (PBMC) was investigated by ELISA in controls homozygous for the polymorphisms studied. Results. The carriage rates of the alleles I and C634 were significantly more frequent in GCA patients than in controls (p = 0.025, OR 1.9, 95% CI 1.1-3.1 and p = 0.015, OR 2.1, 95% CI 1.1-3.6, respectively). The distribution of allele T936 was similar in GCA patients and controls. No significant differences in the distribution of the polymorphisms studied were observed in patients with ischemic manifestations compared to those without ischemic manifestations. Lipopolysaccharide (LPS)-stimulated VEGF production by PBMC from controls was higher in II homozygous compared to DD homozygous patients. Conclusion. Our data indicate that carriers of C634 and I alleles are associated with susceptibility to developing GCA.

Original languageEnglish
Pages (from-to)2160-2164
Number of pages5
JournalJournal of Rheumatology
Volume30
Issue number10
Publication statusPublished - Oct 1 2003

Fingerprint

Giant Cell Arteritis
Vascular Endothelial Growth Factor A
Genes
Alleles
Blood Cells
Blood Donors
Genetic Promoter Regions
Oligonucleotides
Italy
Lipopolysaccharides
Enzyme-Linked Immunosorbent Assay
Biopsy
Polymerase Chain Reaction
Mutation

Keywords

  • Giant cell arteritis
  • Ischemic manifestations
  • Polymorphisms
  • Vascular endothelial growth factor
  • Vegf production

ASJC Scopus subject areas

  • Rheumatology
  • Immunology

Cite this

Vascular endothelial growth factor gene polymorphisms in giant cell arteritis. / Boiardi, Luigi; Casali, Bruno; Nicoli, Davide; Farnetti, Enrico; Chen, Qingquan; Macchioni, Pierluigi; Catanoso, Maria Grazia; Pulsatelli, Lia; Meliconi, Riccardo; Salvarani, Carlo.

In: Journal of Rheumatology, Vol. 30, No. 10, 01.10.2003, p. 2160-2164.

Research output: Contribution to journalArticle

@article{c1e567f4063e4994ab4262759f99f7e7,
title = "Vascular endothelial growth factor gene polymorphisms in giant cell arteritis",
abstract = "Objective. To examine potential associations of vascular endothelial growth factor (VEGF) gene polymorphisms with giant cell arteritis (GCA) and disease expression, in particular in patients with and without ischemic complications. Methods. We enrolled 92 consecutive patients with biopsy-proven GCA residing in Reggio Emilia, Italy. Two hundred healthy blood donors from the same geographic area were selected as controls. All the GCA patients and controls were genotyped by polymerase chain reaction and allele-specific oligonucleotide techniques for 936 C/T and 634 C/G mutations and for an 18 bp insertion/deletion (I/D) polymorphism in the VEGF promoter region. In vitro release of VEGF by peripheral blood mononuclear cells (PBMC) was investigated by ELISA in controls homozygous for the polymorphisms studied. Results. The carriage rates of the alleles I and C634 were significantly more frequent in GCA patients than in controls (p = 0.025, OR 1.9, 95{\%} CI 1.1-3.1 and p = 0.015, OR 2.1, 95{\%} CI 1.1-3.6, respectively). The distribution of allele T936 was similar in GCA patients and controls. No significant differences in the distribution of the polymorphisms studied were observed in patients with ischemic manifestations compared to those without ischemic manifestations. Lipopolysaccharide (LPS)-stimulated VEGF production by PBMC from controls was higher in II homozygous compared to DD homozygous patients. Conclusion. Our data indicate that carriers of C634 and I alleles are associated with susceptibility to developing GCA.",
keywords = "Giant cell arteritis, Ischemic manifestations, Polymorphisms, Vascular endothelial growth factor, Vegf production",
author = "Luigi Boiardi and Bruno Casali and Davide Nicoli and Enrico Farnetti and Qingquan Chen and Pierluigi Macchioni and Catanoso, {Maria Grazia} and Lia Pulsatelli and Riccardo Meliconi and Carlo Salvarani",
year = "2003",
month = "10",
day = "1",
language = "English",
volume = "30",
pages = "2160--2164",
journal = "Journal of Rheumatology",
issn = "0315-162X",
publisher = "Journal of Rheumatology",
number = "10",

}

TY - JOUR

T1 - Vascular endothelial growth factor gene polymorphisms in giant cell arteritis

AU - Boiardi, Luigi

AU - Casali, Bruno

AU - Nicoli, Davide

AU - Farnetti, Enrico

AU - Chen, Qingquan

AU - Macchioni, Pierluigi

AU - Catanoso, Maria Grazia

AU - Pulsatelli, Lia

AU - Meliconi, Riccardo

AU - Salvarani, Carlo

PY - 2003/10/1

Y1 - 2003/10/1

N2 - Objective. To examine potential associations of vascular endothelial growth factor (VEGF) gene polymorphisms with giant cell arteritis (GCA) and disease expression, in particular in patients with and without ischemic complications. Methods. We enrolled 92 consecutive patients with biopsy-proven GCA residing in Reggio Emilia, Italy. Two hundred healthy blood donors from the same geographic area were selected as controls. All the GCA patients and controls were genotyped by polymerase chain reaction and allele-specific oligonucleotide techniques for 936 C/T and 634 C/G mutations and for an 18 bp insertion/deletion (I/D) polymorphism in the VEGF promoter region. In vitro release of VEGF by peripheral blood mononuclear cells (PBMC) was investigated by ELISA in controls homozygous for the polymorphisms studied. Results. The carriage rates of the alleles I and C634 were significantly more frequent in GCA patients than in controls (p = 0.025, OR 1.9, 95% CI 1.1-3.1 and p = 0.015, OR 2.1, 95% CI 1.1-3.6, respectively). The distribution of allele T936 was similar in GCA patients and controls. No significant differences in the distribution of the polymorphisms studied were observed in patients with ischemic manifestations compared to those without ischemic manifestations. Lipopolysaccharide (LPS)-stimulated VEGF production by PBMC from controls was higher in II homozygous compared to DD homozygous patients. Conclusion. Our data indicate that carriers of C634 and I alleles are associated with susceptibility to developing GCA.

AB - Objective. To examine potential associations of vascular endothelial growth factor (VEGF) gene polymorphisms with giant cell arteritis (GCA) and disease expression, in particular in patients with and without ischemic complications. Methods. We enrolled 92 consecutive patients with biopsy-proven GCA residing in Reggio Emilia, Italy. Two hundred healthy blood donors from the same geographic area were selected as controls. All the GCA patients and controls were genotyped by polymerase chain reaction and allele-specific oligonucleotide techniques for 936 C/T and 634 C/G mutations and for an 18 bp insertion/deletion (I/D) polymorphism in the VEGF promoter region. In vitro release of VEGF by peripheral blood mononuclear cells (PBMC) was investigated by ELISA in controls homozygous for the polymorphisms studied. Results. The carriage rates of the alleles I and C634 were significantly more frequent in GCA patients than in controls (p = 0.025, OR 1.9, 95% CI 1.1-3.1 and p = 0.015, OR 2.1, 95% CI 1.1-3.6, respectively). The distribution of allele T936 was similar in GCA patients and controls. No significant differences in the distribution of the polymorphisms studied were observed in patients with ischemic manifestations compared to those without ischemic manifestations. Lipopolysaccharide (LPS)-stimulated VEGF production by PBMC from controls was higher in II homozygous compared to DD homozygous patients. Conclusion. Our data indicate that carriers of C634 and I alleles are associated with susceptibility to developing GCA.

KW - Giant cell arteritis

KW - Ischemic manifestations

KW - Polymorphisms

KW - Vascular endothelial growth factor

KW - Vegf production

UR - http://www.scopus.com/inward/record.url?scp=10744228051&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=10744228051&partnerID=8YFLogxK

M3 - Article

C2 - 14528511

AN - SCOPUS:10744228051

VL - 30

SP - 2160

EP - 2164

JO - Journal of Rheumatology

JF - Journal of Rheumatology

SN - 0315-162X

IS - 10

ER -